{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:32:26Z","timestamp":1793946746120,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023AFA007"],"award-info":[{"award-number":["2023AFA007"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0531600"],"award-info":[{"award-number":["2024ZD0531600"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.diabres.2026.113237","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:52:54Z","timestamp":1775145174000},"page":"113237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic dysfunction-associated fatty liver disease and the risk of incident chronic kidney disease: A 10-year prospective cohort study"],"prefix":"10.1016","volume":"236","author":[{"given":"Hongsheng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113237_b0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1440-1746.2007.05001.x","article-title":"Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines","volume":"22","author":"Chitturi","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2026.113237_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2026.113237_b0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ki.2012.39","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"81","author":"Woo","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2026.113237_b0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.ajkd.2019.05.032","article-title":"CKD in China: evolving Spectrum and Public Health Implications","volume":"76","author":"Yang","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2026.113237_b0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jfma.2019.02.010","article-title":"The correlation between fatty liver disease and chronic kidney disease","volume":"119","author":"Chen","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.diabres.2026.113237_b0045","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/hep.30967","article-title":"Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the multiethnic cohort","volume":"71","author":"Noureddin","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2026.113237_b0050","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","article-title":"Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease","volume":"150","author":"Anstee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2026.113237_b0055","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms17040562","article-title":"NAFLD and chronic kidney disease","volume":"17","author":"Marcuccilli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113237_b0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jdi.13678","article-title":"Metabolic associated fatty liver disease is a risk factor for chronic kidney disease","volume":"13","author":"Hashimoto","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2026.113237_b0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-Year Cohort Study in China","volume":"107","author":"Liang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113237_b0070","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/CM9.0000000000001513","article-title":"Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.diabres.2026.113237_b0075","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2215\/CJN.11971018","article-title":"Genetic and environmental influences on the correlations between traits of metabolic syndrome and CKD","volume":"14","author":"Chen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113237_b0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dys053","article-title":"Cohort profile: the Dongfeng-Tongji cohort study of retired workers","volume":"42","author":"Wang","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.diabres.2026.113237_b0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","article-title":"Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary","volume":"22","author":"Farrell","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0090","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113237_b0095","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2026.113237_b0100","article-title":"FIB-4 first in the diagnostic algorithm of metabolic-dysfunction-associated fatty liver disease in the era of the global metabodemic","volume":"11","author":"Sumida","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.diabres.2026.113237_b0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2026.113237_b0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2026.113237_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101111","article-title":"Genetic and epigenetic factors determining NAFLD risk","volume":"50","author":"Jonas","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.diabres.2026.113237_b0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.diabres.2026.113237_b0135","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/hmg\/ddu583","article-title":"Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci","volume":"24","author":"He","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.diabres.2026.113237_b0140","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.610","article-title":"Estimation of effect size distribution from genome-wide association studies and implications for future discoveries","volume":"42","author":"Park","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2026.113237_b0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b4838","article-title":"Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study","volume":"340","author":"Talmud","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2026.113237_b0150","volume":"115","author":"Sun","year":"2021","journal-title":"MAFLD and Risk of CKD Metabolism"},{"key":"10.1016\/j.diabres.2026.113237_b0155","article-title":"Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: a nationwide cohort study","volume":"48","author":"Jung","year":"2022","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2026.113237_b0160","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2147\/DMSO.S292926","article-title":"Association between metabolic associated fatty liver disease and chronic kidney disease: a cross-sectional study from NHANES 2017-2018","volume":"14","author":"Deng","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2026.113237_b0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2020.06.040","article-title":"FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)","volume":"74","author":"Wu","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0170","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","article-title":"Differential clinical characteristics and mortality outcomes in persons with NAFLD and\/or MAFLD","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0175","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"Thomas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113237_b0180","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113237_b0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.30625","article-title":"Relationship between PNPLA3 rs738409 polymorphism and decreased kidney function in children with NAFLD","volume":"70","author":"Targher","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2026.113237_b0190","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/liv.14419","article-title":"PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: clinical and experimental findings","volume":"40","author":"Mantovani","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.diabres.2026.113237_b0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40620-013-0025-0","article-title":"GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC study","volume":"27","author":"Hishida","year":"2014","journal-title":"J Nephrol"},{"key":"10.1016\/j.diabres.2026.113237_b0200","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbalip.2018.06.018","article-title":"The role of PNPLA3 in health and disease","volume":"1864","author":"Pingitore","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.diabres.2026.113237_b0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/liv.14251","article-title":"PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels","volume":"40","author":"Sun","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.diabres.2026.113237_b0210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/db08-1277","article-title":"Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents","volume":"58","author":"Tam","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113237_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137007","article-title":"MAFLD and CKD: an updated narrative review","volume":"23","author":"Mantovani","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113237_b0220","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.biochi.2013.07.017","article-title":"Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function","volume":"95","author":"Guebre-Egziabher","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.diabres.2026.113237_b0225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-a, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113237_b0230","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.diabres.2026.113237_b0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113237_b0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.diabres.2026.113237_b0250","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jlts.2002.36740","article-title":"One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation","volume":"8","author":"Ryan","year":"2002","journal-title":"Liver Transpl"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:59:57Z","timestamp":1793944797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726001567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"alternative-id":["S0168822726001567"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113237","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction-associated fatty liver disease and the risk of incident chronic kidney disease: A 10-year prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113237"}}